共 50 条
- [1] Benralizumab (Fasenra) for Severe Eosinophilic Asthma (Reprinted from The Medical Letter on Drugs and Therapeutics, vol 60, pg 33, 2018) [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 319 (14): : 1501 - 1502
- [2] OUTCOMES WITH MEPOLIZUMAB AND BENRALIZUMAB IN SEVERE EOSINOPHILIC ASTHMA [J]. THORAX, 2021, 76 : A142 - A142
- [3] Efficacy of Benralizumab in patients with severe eosinophilic asthma [J]. PNEUMOLOGIE, 2023, 77 : S25 - S26
- [5] Effectiveness of Switching to Benralizumab in Severe Refractory Eosinophilic Asthma [J]. JOURNAL OF ASTHMA AND ALLERGY, 2022, 15 : 727 - 735
- [10] Eosinophilic granulomatosis with polyangiitis evolution during severe eosinophilic asthma treatment with benralizumab [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2020, 8 (07): : 2448 - 2449